Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, announced that it has signed agreements with six additional health plans across 10 states bringing the Company’s total national contracted membership to more than 174 million lives. Response Genetics, Inc. (NASDAQ:RGDX) shares after opening at $1.35 moved to $1.56 on last trade day and at the end of the day closed at $1.42. Company price to sales ratio in past twelve months was calculated as 2.68 and price to cash ratio as 11.94. Response Genetics, Inc. (NASDAQ:RGDX) showed a positive weekly performance of 26.79%.
Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced the pricing of its previously announced underwritten public offering of 11,325,000 shares of its common stock at an offering price of $2.21 per share. Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) shares advanced 8.60% in last trading session and ended the day on $2.40. CPRX return on equity ratio is recorded as -73.10% and its return on assets is -59.70%. Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) yearly performance is 433.33%.
RadNet, Inc. (NASDAQ:RDNT) was a big mover last session, as its shares rose nearly 12% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since March 26, as the stock is now up over 23%. RadNet Inc. (NASDAQ:RDNT) shares moved up 5.28% in last trading session and was closed at $3.39 while trading in range of $3.19 – $3.46 – RadNet Inc. (NASDAQ:RDNT) year to date (YTD) performance is 102.99%.
EDAP TMS SA (ADR) (NASDAQ:EDAP) the global leader in therapeutic ultrasound, announced financial results for the fourth quarter and year ended December 31, 2013, and provided an update on recent strategic developments. EDAP TMS S.A. (ADR) (NASDAQ:EDAP) weekly performance is 13.48%. On last trading day company shares ended up $3.20. EDAP TMS S.A. (ADR) (NASDAQ:EDAP) distance from 50-day simple moving average (SMA50) is 0.51%. Analysts mean target price for the company is $6.00.